Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis.
Regueiro C, Rodriguez-Rodriguez L, Lopez-Mejias R, Nuño L, Triguero-Martinez A, Perez-Pampin E, Corrales A, Villalba A, Lopez-Golan Y, Abasolo L, Remuzgo-Martínez S, Ortiz AM, Herranz E, Martínez-Feito A, Conde C, Mera-Varela A, Balsa A, Gonzalez-Alvaro I, González-Gay MÁ, Fernandez-Gutierrez B, Gonzalez A. Regueiro C, et al. Among authors: villalba a. Sci Rep. 2020 Oct 22;10(1):18372. doi: 10.1038/s41598-020-75520-9. Sci Rep. 2020. PMID: 33093527 Free PMC article.
The timing of serum infliximab loss, or the appearance of antibodies to infliximab (ATI), is related with the clinical activity in ATI-positive patients with rheumatoid arthritis treated with infliximab.
Plasencia Ch, Pascual-Salcedo D, Alcocer P, Bonilla MG, Villalba A, Peiteado D, Arribas F, Díez J, Lopez-Casla MT, Martín-Mola E, Balsa A. Plasencia Ch, et al. Among authors: villalba a. Ann Rheum Dis. 2013 Nov;72(11):1888-90. doi: 10.1136/annrheumdis-2013-203353. Epub 2013 Jun 5. Ann Rheum Dis. 2013. PMID: 23740237 No abstract available.
Effect of Infliximab Dose Increase in Rheumatoid Arthritis at Different Trough Concentrations: A Cohort Study in Clinical Practice Conditions.
Plasencia C, Jurado T, Villalba A, Peitedado D, Casla MT, Nuño L, Bonilla MG, Martínez-Feito A, Martín-Mola E, Pascual-Salcedo D, Balsa A. Plasencia C, et al. Among authors: villalba a. Front Med (Lausanne). 2015 Oct 8;2:71. doi: 10.3389/fmed.2015.00071. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26501060 Free PMC article.
Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.
Plasencia C, Wolbink G, Krieckaert CL, Kneepkens EL, Turk S, Jurado T, Martínez-Feito A, Navarro-Compán V, Bonilla G, Villalba A, Peiteado D, Nuño L, Martín-Mola E, Nurmohamed MT, van der Kleij D, Rispens T, Pascual-Salcedo D, Balsa A. Plasencia C, et al. Among authors: villalba a. Clin Exp Rheumatol. 2016 Jul-Aug;34(4):655-62. Epub 2016 May 19. Clin Exp Rheumatol. 2016. PMID: 27214767
Golimumab Tapering Strategy Based on Serum Drug Levels in Patients With Spondyloarthritis.
Redondo C, Martínez-Feito A, Plasencia-Rodríguez C, Navarro-Compán V, Nuño-Nuño L, Peiteado D, Villalba A, Jochems A, Pascual-Salcedo D, Balsa A. Redondo C, et al. Among authors: villalba a. Arthritis Rheumatol. 2018 Aug;70(8):1356-1358. doi: 10.1002/art.40542. Epub 2018 Jul 2. Arthritis Rheumatol. 2018. PMID: 29736972 No abstract available.
Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinics.
Regueiro C, Rodríguez-Martínez L, Nuño L, Ortiz AM, Villalba A, Pascual-Salcedo D, Martínez-Feito A, González-Alvaro I, Balsa A, Gonzalez A. Regueiro C, et al. Among authors: villalba a. Arthritis Res Ther. 2019 Dec 11;21(1):280. doi: 10.1186/s13075-019-2079-4. Arthritis Res Ther. 2019. PMID: 31829260 Free PMC article.
200 results